A Study of Pregnancy and Pregnancy Outcomes in Women With Breast Cancer Treated With Trastuzumab, Pertuzumab in Combination With Trastuzumab, or Ado-Trastuzumab Emtansine (MotHER)
This study is currently recruiting participants.
Verified May 2017 by Genentech, Inc.
Information provided by (Responsible Party):
First received: January 30, 2009
Last updated: May 30, 2017
Last verified: May 2017
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is currently recruiting participants.|
|Estimated Study Completion Date:||January 31, 2025|
|Estimated Primary Completion Date:||January 31, 2025 (Final data collection date for primary outcome measure)|